http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
Sartorius closes fiscal 2021 with 50 percent growth and a jump in profitability
-
Sartorius strengthens its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions
-
Sartorius grows operations in France and is investing 100 million euros by 2025
-
Sartorius significantly expands activities in South Korea
-
Sartorius grows dynamically and profitably - Substantial double-digit increases in sales and earnings
-
Change in Composition of Sartorius Joint Heirship
-
Sartorius to expand Business Operations in North America
-
Sartorius to Open New Application and Service Hub in Shanghai
-
Sartorius To Join The DAX Blue Chip Index
-
Sartorius acquires cell culture specialist Xell AG
-
Sartorius strengthens product portfolio for cell and gene therapies by acquiring a majority stake in CellGenix
-
Sartorius with first-quarter uptick in sales and earnings
-
Resolutions of the Annual Shareholders' Meeting of Sartorius AG
-
Sartorius is a corporate partner of the Healthcare Businesswomen's Association
-
Sartorius looks back on a very successful 2020 and expects further strong growth
-
Resolutions of the Supervisory Board of Sartorius AG
-
Sartorius to acquire Novasep's chromatography process equipment division
-
Sartorius closes acquisition of BIA Separations
-
Sartorius With Dynamic Growth in the First Half; 2020 Sales and Earnings Forecast Raised
-
Sartorius Signs European Plastics Pact
-
Sartorius Achieves Significant Increases in Sales Revenue and Earnings Again in 2019 and is set to Grow Further

